Louis Boon

26PUBLICATIONS
303CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityLiquid biopsiesTumour immunologyInfectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 31, 2026
Neutralizing the IL-12/IL-23 p40 subunit prevents immune checkpoint blockade toxicity without compromising antitumor efficacy.

|Jul 16, 2026
The unfolded protein sensor IRE1 is essential for homeostatic dendritic cell maturation.

|Apr 23, 2026
Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-Seq.

|Sep 17, 2025
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.

Sana M Arnouk, Daliya Kancheva, Helena Van Damme

|Aug 28, 2025
IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti-PD-1 Therapy in Tumor-Bearing Mice.

Jelena Gabrilo, Sylvie Vande Velde, Coralie Henin

|Jul 09, 2025
Macrophage IL-4 polarization is restricted by soluble CD40 agonists and antigen-induced CD154 but not by constitutive CD154 expressed by CD4+ T cells.

Mariana Suárez-Martins, Ignacio González-Alayón, Cecilia Casaravilla

Pageof 5

Frequent Collaborators

4 joint publications

Sophie Janssens

3 joint publications

Daliya Kancheva

3 joint publications

Bart N Lambrecht

3 joint publications

Victor Bosteels